Literature DB >> 2221648

Regional deposition of aerosolized pentamidine. Effects of body position and breathing pattern.

M I Baskin1, A G Abd, J S Ilowite.   

Abstract

OBJECTIVE: To evaluate the effects of varying body position and breathing pattern on overall lung distribution of aerosolized pentamidine.
DESIGN: Nonrandomized control trial with four weekly inhalational treatments.
SETTING: The nuclear medicine department of a voluntary hospital. PATIENTS: Sixteen men with the acquired immunodeficiency syndrome (AIDS) or positive serology for the human immunodeficiency virus (HIV). Thirteen patients (81%) completed the study.
INTERVENTIONS: Patients inhaled a solution of either saline and technetium-99m bound to diethylenetriamine penta-acetic acid or sterile water, pentamidine (60 mg), and technetium-99m bound to human serum albumin. On weekly visits, the patients inhaled the aerosol solution using four methods: sitting, supine, sitting with an abdominal binder, and sitting and breathing from residual volume with a shallow inspiration.
MEASUREMENTS AND MAIN RESULTS: Deposition scans, obtained after each aerosol inhalation, were superimposed on each patient's equilibrium xenon scan, and a frequency distribution histogram was constructed. An asymmetry index was determined from this histogram. The lower the asymmetry index, the more homogeneous the aerosol distribution. Only use of the supine position showed a significant decrease in the asymmetry index (mean, 0.34 +/- 0.02 in the supine position, 0.48 +/- 0.03 in the sitting position; P less than 0.001).
CONCLUSIONS: Aerosol distribution in the lungs was more uniform when administered to patients in the supine position. Patients receiving aerosolized pentamidine may benefit from inhalation in the supine position; these results should be verified by clinical study.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2221648     DOI: 10.7326/0003-4819-113-9-677

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  9 in total

Review 1.  Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications.

Authors:  N R Labiris; M B Dolovich
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

2.  Opportunistic infections in HIV-infected patients.

Authors:  S D Shafran
Journal:  Can J Infect Dis       Date:  1992-03

Review 3.  Clinical pharmacokinetics of inhaled antimicrobials.

Authors:  Chris Stockmann; Jessica K Roberts; Venkata K Yellepeddi; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2015-05       Impact factor: 6.447

4.  Study of the three-dimensional geometry of the central conducting airways in man using computed tomographic (CT) images.

Authors:  V Sauret; P M Halson; I W Brown; J S Fleming; A G Bailey
Journal:  J Anat       Date:  2002-02       Impact factor: 2.610

Review 5.  Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis.

Authors:  J Beyer; S Schwartz; G Barzen; G Risse; K Dullenkopf; C Weyer; W Siegert
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

6.  The use of an alternate side lying positioning strategy during inhalation therapy does not prolong nebulisation time in adults with Cystic Fibrosis: a randomised crossover trial.

Authors:  Ruth L Dentice; Mark R Elkins; Genevieve M Dwyer; Peter T P Bye
Journal:  BMC Pulm Med       Date:  2018-01-08       Impact factor: 3.317

7.  Development of an ex vivo human-porcine respiratory model for preclinical studies.

Authors:  Sophie Perinel; Jérémie Pourchez; Lara Leclerc; John Avet; Marc Durand; Nathalie Prévôt; Michèle Cottier; Jean M Vergnon
Journal:  Sci Rep       Date:  2017-02-24       Impact factor: 4.379

Review 8.  Fundamentals of aerosol therapy in critical care.

Authors:  Jayesh Dhanani; John F Fraser; Hak-Kim Chan; Jordi Rello; Jeremy Cohen; Jason A Roberts
Journal:  Crit Care       Date:  2016-10-07       Impact factor: 9.097

9.  Development of an ex vivo respiratory pediatric model of bronchopulmonary dysplasia for aerosol deposition studies.

Authors:  Yoann Montigaud; Sophie Périnel; Jean-Christophe Dubus; Lara Leclerc; Marie Suau; Clémence Goy; Anthony Clotagatide; Nathalie Prévôt; Jérémie Pourchez
Journal:  Sci Rep       Date:  2019-04-05       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.